CompoAtlas

Polyflora O

Food supplement declared in France, declaration No 2024-8-1019, decision dated 23 August 2024

Polyflora O (North American Pharmacal) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
North American Pharmacal
Food business operator placing the product on the market
Karen Vago
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Capsule
Daily dose
4
Intended populations
Homme, Femme
Not recommended for (according to the manufacturer)
Femmes allaitantes, Enfants (moins de 12 ans), Femmes enceintes
Objectives stated by the manufacturer (these are not authorised claims)
Transit, Digestion, Gestion du poids / minceur, Immunité, Minceur / Ventre plat

Declaration 155001, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

None of the rules we check applies to the declared ingredients.

Declared composition

Plants

PlantPartPreparationPer day
Cichorium intybus L.RacineAutre extrait sec200 mg
Musa × paradisiaca L.FruitAutre extrait sec200 mg

Other active ingredients

NamePer day
Arabinogalactanesnot declared

Micro-organisms

StrainPer day
Akkermansia muciniphila AH3910,000,000,000,000 (unit not declared)
Streptococcus Thermophilus SD-52074,800,000,000,000 (unit not declared)
Lactobacillus Rhamnosus SD-58394,800,000,000,000 (unit not declared)
cerevisiae boulardii Saccharomyces DBVPG 67684,000,000,000,000 (unit not declared)

Additives

E460

Other ingredients

Extrait de riz, Concentré de riz

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

List recorded in 2024. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.

Label warnings

L'Akkermansia doit être consommé seulement par des adultes à l'exclusion des femmes enceintes ou allaitantes.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Brand : North American Pharmacal

List recorded in 2024. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line